» Articles » PMID: 35937515

Is C1q Nephropathy Associated with a WDR19 Gene Mutation? A Case Report

Overview
Journal Hippokratia
Specialty General Medicine
Date 2022 Aug 8
PMID 35937515
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Even though complement 1q nephropathy (C1qN) was first introduced in 1985, this entity is still unknown and recognized by clinicians due to its rare prevalence (0.2 - 2.5 %) and insufficient emphasis.

Description Of The Case: A 50-year-old woman was incidentally found to have non-nephrotic proteinuria with a normal glomerular filtration rate. Renal biopsy revealed C1qN with severe fibrosis. The presence of consanguinity and kidney diseases in family members of the patient led to genetic research, and homogenous mutation of c.991G>T (p.G331C) in the WD-repeat domain 19 ( gene was found. The same homozygous and heterozygous mutations in the gene were found in the relatives of our patient with kidney diseases. One year of follow-up with methylprednisolone and mycophenolate mofetil treatment resulted in partial remission of the kidney disease.

Conclusion: Renal biopsy for patients with non-nephrotic proteinuria without delay is suggested as it might be a surrogate marker of severe injury. Genetic mutations in the gene should be searched for C1qN pathogenesis. This is the first adult case report on C1qN from Turkey.HIPPOKRATIA 2021, 25 (2):87-90.

Citing Articles

Compound heterozygous variants associated with nephronophthisis, Caroli disease, refractory epilepsy and congenital bilateral central blindness: Case report.

Tang X, Yi S, Qin Z, Yi S, Chen J, Yang Q Heliyon. 2024; 10(1):e23257.

PMID: 38163131 PMC: 10754840. DOI: 10.1016/j.heliyon.2023.e23257.

References
1.
Sonneveld R, Hoenderop J, Isidori A, Henique C, Dijkman H, Berden J . Sildenafil Prevents Podocyte Injury PPAR--Mediated TRPC6 Inhibition. J Am Soc Nephrol. 2016; 28(5):1491-1505. PMC: 5407711. DOI: 10.1681/ASN.2015080885. View

2.
Tariq N, Nasir H, Ahmed T, Usman M, Ahmed K . C1Q Nephropathy: A Multifaceted Disease With Infrequent Diagnosis. J Ayub Med Coll Abbottabad. 2019; 31(3):308-313. View

3.
Yang J, Zhang B . [Advances in clinical research on C1q nephropathy]. Zhongguo Dang Dai Er Ke Za Zhi. 2016; 18(11):1194-1198. PMC: 7389859. View

4.
De Vriese A, Sethi S, Nath K, Glassock R, Fervenza F . Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach. J Am Soc Nephrol. 2018; 29(3):759-774. PMC: 5827609. DOI: 10.1681/ASN.2017090958. View

5.
Akilesh S, Suleiman H, Yu H, Stander M, Lavin P, Gbadegesin R . Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J Clin Invest. 2011; 121(10):4127-37. PMC: 3195463. DOI: 10.1172/JCI46458. View